Martin W Huellner Selected Research

Martin W Huellner Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 01/2014
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2014
4	Adenoma (Adenomas) 06/2022 - 10/2018
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2022 - 04/2019
3	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2020
3	Alveolar echinococcosis 01/2022 - 08/2021
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 02/2022 - 10/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2014
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Peripheral Arterial Disease 08/2021 - 01/2019
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 12/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2020
2	Aneurysm (Aneurysms) 01/2021 - 06/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 03/2015
1	Primary Hyperparathyroidism 02/2022
1	Leukocytosis (Pleocytosis) 02/2022
1	Bullous Pemphigoid (Pemphigoid) 02/2022
1	Lymphadenopathy 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	COVID-19 01/2022
1	Myoepithelioma 01/2022
1	Pleomorphic Adenoma 01/2022
1	Solitary Fibrous Tumors 09/2021
1	Hemangiopericytoma 09/2021
1	Lung Diseases (Lung Disease) 03/2021
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Oligodendroglioma 11/2020
1	Infected Aneurysm 06/2020
1	Paralysis (Palsy) 02/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Lymphatic Metastasis 01/2020
1	Adenocarcinoma 04/2019
1	Demyelinating Diseases (Demyelinating Disease) 11/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2016
1	Hyperplasia 03/2016
1	Secondary Hyperparathyroidism 03/2016
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2015
1	Hypophysitis 11/2015

Drug/Important Bio-Agent (IBA)

8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 04/2021 - 12/2019
5	Cytidine Triphosphate (CTP)IBA 08/2021 - 01/2014
3	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2020
2	Parathyroid Hormone (Parathormone)IBA 02/2022 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2020
2	benzimidazoleIBA 01/2022 - 08/2021
2	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 11/2020 - 11/2018
2	fluorocholineIBA 10/2018 - 03/2016
1	Oligoclonal BandsIBA 02/2022
1	fluoromethylcholineIBA 02/2022
1	cemiplimabIBA 02/2022
1	VaccinesIBA 01/2022
1	RadiopharmaceuticalsIBA 01/2022
1	5'-N-methylcarboxamideadenosineIBA 01/2022
1	Fluorine-18IBA 01/2022
1	AntibodiesIBA 08/2021
1	thiamine triphosphorate (TTP)IBA 06/2021
1	AntigensIBA 04/2021
1	gallium Ga 68 dotatateIBA 01/2021
1	Peptide Receptors (Peptide Receptor)IBA 12/2020
1	Radioisotopes (Radionuclides)IBA 12/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2020
1	CalciumIBA 10/2018
1	SiliconIBA 09/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016
1	Hematoxylin (Haematoxylon)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	IpilimumabIBA 11/2015
1	Contrast MediaIBA 12/2014
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2014

Therapy/Procedure

8	Therapeutics 01/2022 - 06/2020
2	Parathyroidectomy 06/2022 - 01/2021
2	Immunotherapy 02/2022 - 04/2021
2	Duration of Therapy 01/2022 - 08/2021
1	Adjuvant Radiotherapy 09/2021
1	Radiotherapy 01/2021
1	Denervation 02/2020
1	Chemoradiotherapy 01/2020
1	Neck Dissection (Radical Neck Dissection) 01/2018
1	Drug Therapy (Chemotherapy) 01/2016
1	Neoadjuvant Therapy 01/2016